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26
Glucose metabolism is subjected to diurnal variation, which might be mediated by alterations in 27 the transcription pattern of clock genes and regulated by hormonal factors, as has been 28 demonstrated for insulin. However, whether also glucagon is involved in the diurnal variation of 29 glucose homeostasis is not known. We therefore examined glucagon secretion after meal 30 ingestion (meal tolerance test) and during hypoglycemia (hyperinsulinemic hypoglycemia clamp 31 at 2.5 mmol/l glucose) and in vitro from isolated islets at ZT3 versus ZT15 in normal C57BL/6J 32 mice and, furthermore, glucose levels and the insulin response to meal ingestion were also 33 examined at these time points in glucagon receptor knockout mice (GCGR-/-) and their wildtype 34 (wt) littermates. 35 We found in normal mice that whereas the glucagon response to meal ingestion was not 36 different between ZT3 and ZT15, the glucagon response to hypoglycemia was lower at ZT3 than 37 at ZT15 and glucagon secretion from isolated islets was higher at ZT3 than at ZT15. GCGR-/-38 mice displayed lower basal glucose, a lower insulin response to meal and a higher insulin 39 sensitivity than wt mice at ZT3 but not at ZT15. We conclude that glucagon secretion displays a 40 diurnal variability which is dependent both on intraislet and extraislet regulatory mechanisms in 41 normal mice and that the phenotype characteristics of a lower glucose and reduced insulin 42 response to meal in GCGR-/. mice are evident only during the light phase. These findings 43 suggest that glucagon signaling is a plausible contributor to the diurnal variation in glucose 44 homeostasis which may explain that the phenotype of the GCGR-/-mice is dependent on the 45 time of the day when it is examined. 46 that an autonomic rhythm exists within pancreatic beta cells (11, 12) and that conditional 69 disruption of the clock in the pancreas results in impaired beta cell function and diabetes (13). 70
Recently, it was demonstrated that the pancreatic glucagon producing alpha cells is regulated 71
by the clock gene Rev-erb alpha such that silencing of this gene inhibits glucagon secretion 72 whereas a Rev-erb alpha agonist stimulates glucagon secretion (14). This would suggest that not 73 only insulin but also glucagon is the subjects of diurnal variation through clock regulation. This 74 would be of interest since glucagon stimulates hepatic glucose production which is a key 75 mechanism for preventing hypoglycemia during the inactive phase (1). Interestingly, it has also 76 been reported but not widely discussed, that the phenotype characteristic of a reduction in 77 circulating glucose in glucagon receptor knockout (GCGR-/-) mice is observed only in the 78 morning hours and vanishes later during the day (15), which may further indicate that glucagon 79 is involved in the diurnal variation of glucose homeostasis. 80
However, besides these studies there is little evidence linking glucagon signaling or glucagon 81 secretion to diurnal variation of glucose homeostasis. To gain further insight in the potential 82 involvement of glucagon in this respect, we compared the glucagon response to hypoglycemia 83 and meal test, and glucagon secretion from isolated islets between zetigeber time (ZT) 3 and 84 ZT15 in normal mice and compared glucose levels and insulin response to meal in GCGR -/-mice 85 and their wildtype littermates. 86 87
Materials and methods 88
Animals and anesthesia 89
Female C57BL/6J mice were obtained from Taconic (Skensved, Denmark) and housed on arrival 90 at 22° in a 12h light-dark cycle (6 am to 6 pm). The generation of GCGR-/-mice and their 91 wildtype littermates has been described previously (15). A standard research diet R34 92 (Lantmännen, Stockholm, Sweden) and water was provided ad lib. Mice were anesthetized prior 93 to all experiments using an intraperitoneal injection of midazolam (18 mg/kg animal, Dormicum, 94
Hoffman-La Roche, Basel, Switzerland) and Fluanisone/Fentanyl (41/9 mg/kg animal 95 respectably, Hypnorm, Janssen, Beerse, Belgium). All experimental procedures were performed 96 in agreement with the Animal Ethics Committee in Lund, Sweden.The experiments were 97 performed at ZT 3 (9 am) and ZT15 (9 pm) in regard to glucose homeostasis after meal challenge 98 and during hypoglycemia. Some data were also collected at ZT9 (3 pm) and ZT21 (3 am). 99
Mixed meal tolerance test (MTT) 100
The MTT was performed following 5 h of fasting. A 60/20/20E% Glucose/Protein/Lipid mixed 101 meal solution was administered as a 500 µL gavage as previously described (16). Blood samples 102 were collected from the retrobulbar intraorbital capillary plexus before (0 min) and at 15, 30, 45 103 and 60 min in the experimental series for measurements of insulin or at 5, 10 and 20 min in the 104 experimental series for measurements of glucagon following oral gavage. Plasma samples for 105 glucose and hormone determination were stored at -20° awaiting analysis. 106
Hypoglycemic hyperinsulinemic clamp 107
The hypoglycemic clamp was performed following 5 h of fasting. Surgery and clamp 108 experiments were performed as previously described (17) with the protocol modification of 109 returning of red blood cells (18). Briefly, the right jugular vein and the left carotid artery were 110 catheterized using catheters filled with heparinized saline (100 U/mL). The mice remained 111 anesthetized to reduce variation in the blood glucose concentrations due to stress. Following 112 baseline sampling, synthetic human insulin (Actrapid®, Novo Nordisk, Bagsvaerd, Denmark) was 113 infused as a continuous infusion (15 mU/kg animal/min) at a pace of 2 μL/min for 90 minutes. 114
Blood glucose in ~5 μL whole blood was determined every 10 minutes with an Accu-Chek Aviva 115 blood glucose monitor (Hoffman-LaRoche). A variable amount of a 10% glucose (Sigma-Aldrich, 116 MO, USA) solution was infused to maintain blood glucose levels at 2.5 mmol/L. Glucose 117 requirement to maintain target glucose was represented by the glucose infusion rate (GIR) 118 during the final 30 min steady state of the clamp. 119
Islet experiments 120
Pancreatic islets were isolated at ZT3 and ZT15 by collagenase digestion and handpicked under 121 the microscope. Batches of freshly isolated islets were pre-incubated in HEPES balanced salt 122 solution containing 125 mmol/L NaCl, 5.9 mmol/l KCL, 1.28 mmol/L CaCl2, 1.2 mmol/L MgCl2, 123 25 mmol/L HEPES (pH 7.4), 5.6 mmol/L glucose and 0.1% fatty acid free BSA (Boehringer 124
Mannheim, Mannheim, Germany) at 37°C during 60 min. Thereafter, islets in groups of three 125 were incubated in 200 μl of the above described buffer but with 2.8 and 11.1 mM glucose without 126 or with addition of arginine (10 mM) at 37°C during 60 min. Aliquots of the buffer were 127 collected and stored at -20°C until analysis of insulin levels. was calculated using the trapezoidal rule. 144
Results 146
Glucagon response to meal ingestion in normal mice 147
Whereas baseline blood glucose did not differ between ZT3 and ZT15 (Fig. 1A) , glucose 148 excursion after MTT was lower at ZT3 compared to ZT15 at 10 min (Fig. 1A) . In contrast, there 149 was no significant difference in the glucagon response to MTT between ZT3 and ZT15 (Figs. 1B  150 and 1C). 151
Glucagon response to hypoglycemia in normal mice 152
To study the glucagon response to hypoglycemia, hyperinsulinemic hypoglycemic clamp at 2.5 153 mmol/L was undertaken at ZT3 and ZT15 in normal mice; at this glucose level a robust glucagon 154 response is provoked (18). Basal blood glucose or blood glucose during the clamp did not differ 155 between ZT3 and ZT15 ( Fig. 2A) but the GIR needed to maintain target blood glucose of 2.5 156 mmol/L was significantly lower at ZT3 compared to ZT15 (Figs. 2B and 2C). Consequently, 157 insulin sensitivity (SIClamp) was higher at ZT15 than at ZT3 (4.8±0.9 vs 1.5±0.2 L/kg x min, 158 p=0.003, Fig. 2E ) and so was glucose clearance per unit of insulin (2.1±0.5 vs 0.6±0.1 L 2 /kg x min 159 x mmol, p=0.006; Fig. 2F ). The glucagon response to hypoglycemia was significantly higher at 160 ZT15 than at ZT3, both when measured in absolute concentrations (7.5±1.2 vs 3.3±1.5 pmol/L, 161 p=0.019; Fig. 2G ) and when estimated as fold change over basal (4.8±1.2 vs 1.9±0.54, p=0.035; 162 Fig. 2H) . 163
Glucagon secretion from isolated islets 164
Glucagon secretion from isolated islets from normal mice at 2.8 or 11.1 mmol/L was not 165 different at ZT3 versus ZT15. However, glucagon secretion in response to 10 mmol/Larginine was higher at ZT3 than at ZT15 both at 2.8 mmol/L and 11.1 mmol/L g lucose (both 167 p<0.001). Figs. 3A-C) . GCGR-/-mice had also a lower insulin response to 172 meal than wt mice at ZT3 and ZT9 but not at ZT15 (Figs. 3D-G) . Insulin sensitivity, measured as 173 QUICKI after meal ingestion, was lower in GCGR-/-than in wt mice at ZT3 and ZT9, but not at 174 ZT15 (Fig. 3H) . 175
Discussion 177
As most species, both mice and humans exhibit oscillatory patterns in behavior and 178 physiological functions over the course of the day (1). Central and peripheral gene clocks 179 regulate this and they are in turn regulated by the effect of light on the retina of the eye (4,5), 180 by food intake (21,22) as well as by specific metabolic hormones (23). In this study, we have 181 explored the potential role of glucagon in this respect by examining the glucagon secretion 182 during hypoglycemia and after meal ingestion as well as in vitro at ZT3 versus ZT15 in normal 183 C57BL/6J mice and basal and postprandial glucose levels were also examined at these time 184 points in GCGR-/-mice and their wildetype (wt) littermates. 185
A main general novel finding of this study is that there indeed is a diurnal variability in glucagon 186 secretion in normal mice. The detail of this variability is, however, dependent on the 187 experimental condition. Thus, whereas the glucagon counterregulation to hypoglycemia is lower 188 at ZT3 than at ZT15, arginine-stimulated glucagon secretion from isolated islets shows the 189 opposite pattern, being higher at ZT3 than at ZT15, and glucose-dependent glucagon secretion 190 from islets and the glucagon secretion to meal ingestion is the same at ZT3 and ZT15. Therefore protein resembling a mixed meal was administered to mice (16). In this model, glucagon 213 secretion is stimulated, which is mainly achieved by a combination of fatty acids and amino 214 acids derived from the meal constituents. We found that there was no difference in the 215 glucagon response to meal ingestion when we compared ZT3 and ZT15, suggesting that in 216 contrast to the glucagon counterregulation to hypoglycemia, there is no evidence of a diurnal 217 variability in the glucagon response to meal ingestion. It was therefore a surprise when we 218 documented a clear diurnal variability in glucagon secretion from islets in response to arginine,both at low and high glucose, with a higher glucagon secretion at ZT3 than at ZT15. This shows 220 an interesting diurnal variability in the capacity to secrete glucagon, which is not reflected in a 221 similar difference in vivo with a more modest stimulation. The mechanism and potential 222 contribution of this diurnal variability needs now to be examined in more detail. 223
To examine whether the diurnal variability in glucagon secretion is important for glucose 224 homeostasis, we assessed the hormonal response to a meal ingestion in GCGR-/-mice and wt 225 controls. As reported previously, a characteristic phenotype in GCGR-/-mice is lower baseline 226 glucose, impaired insulin secretion after arginine stimulation and enhanced insulin sensitivity 227 (15,25). We confirm here that these mice, compared to their wt littermates, have reduced 228 baseline glucose, reduced insulin response to meal ingestion and increased insulin sensitivity. 229
However, the main finding in this respect is that these phenotype characteristics were evident 230 only at ZT3 and not seen at ZT15. This further suggests a potential contribution of glucagon to 231 diurnal variability of glucose homeostasis. However, the mechanisms explaining these 232 discrepancies between ZT3 and ZT15 in GCGR-/-mice remain to be established. Due to hyper-233 production of pro-glucagon, the GCGR -/-animals have increased levels of both glucagon and 234 glucagon-like peptide-1 (GLP-1) (25), which might contribute to the phenotype in these animals. 235
However, although recent studies have suggested that GLP-1 has a circadian rhythm (26), it 236 remains yet to be shown whether it affects peripheral gene clocks. It would be interesting to 237 test this, as a recent paper did (27), in a double knockout model. Nevertheless, a consequence 238 of our findings is that the well known phenotype of these mice with reduction of glucose levels 239 and impaired insulin secretion (15,25) depends on the time of the day when it is measured. In a 240 mouse models where a diurnal variation in glucose homeostasis might exaggerate or occlude 242 the phenotype and it highlights the importance of time dependent effects in metabolic 243 phenotyping. Furthermore, the true circadian rhythm in glucose homeostasis with particular 244 attention to glucose needs now to be tested over the entire 24 hr period in at least two cycles. 245
In conclusion, glucagon secretion displays a diurnal variability which is dependent both on 246 intraislet and extraislet regulatory mechanisms in normal mice and, furthermore, the phenotype 247 characteristics of a lower glucose, reduced insulin response to meal and lower insulin sensitivity 248 in GCGR-/-mice are evident only during the light phase. Our results therefore suggest that there 249 is a link between glucagon signaling and the diurnal variation of glucose homeostasis and that 250 the phenotype of the GCGR-/-mice is dependent on the time of the day when it is examined. Table 1 Glucagon secretion from isolated islets from C57BL/6J mice after incubation for 1 hr in 360 glucose at 2.8 mmol/L or 11.1 mmol/L without or with addition of aarginine at 10 mmol/L at ZT3 361 or ZT15. A total of 24 incubations with 3 islets in each from 3 mice were performed. Means ± 362 S.E.M. are shown. 363
364
Glucagon ZT3 (pg/islet/hr) Glucagon ZT15 (pg/islet/hr) 2.8 mmol/L glucose 3.9±0.7 3.6±0.7 2.8 mmol/L glucose +10 mmol/L arginine 9.2±1.0 6.3±0.9 11.1 mmol/L glucose 3.0±0. 
